---
schema_version: "secwatch.filing_event.v1"
accession: "0001679363-24-000004"
form_type: "8-K"
ticker: null
cik: "0001679363"
company_name: "Morphic Holding, Inc."
filed_at: "2024-01-03T23:59:59+00:00"
generated_at: "2026-06-07T04:43:31.125306+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CEO Praveen Tipirneni returns from medical leave, resumes role effective Jan 2, 2024

## Summary
- Dr. Tipirneni resumed day-to-day operational responsibilities as CEO and principal executive officer.
- Bruce Rogers stepped down as interim principal executive officer, remains President of Morphic.
- Tipirneni will present at the 42nd Annual J.P. Morgan Healthcare Conference on Jan 10, 2024.

## SEC filing metadata
- accession: 0001679363-24-000004
- form_type: 8-K
- cik: 0001679363
- company_name: Morphic Holding, Inc.
- filed_at: 2024-01-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1679363/000167936324000004/0001679363-24-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1679363/000167936324000004/morf-20240102.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001679363-24-000004
- JSON: https://secwatch.observer/filing/0001679363-24-000004.json
- Plain text: https://secwatch.observer/filing/0001679363-24-000004.txt

## Key facts
- Executive change
  Bruce N. Rogers changed role as interim principal executive officer at Morphic Holding, Inc..
  - Action: is no longer
  - Role: interim principal executive officer
  source text: Bruce N. Rogers, Ph.D., the Company’s President, is no longer the Company’s interim principal executive officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1679363/000167936324000004/0001679363-24-000004-index.htm
- Executive change
  Praveen Tipirneni changed role as Chief Executive Officer at Morphic Holding, Inc..
  - Action: resumed
  - Role: Chief Executive Officer
  source text: Effective as of January 2, 2024, Dr. Tipirneni has resumed his day-to-day operational responsibilities at the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1679363/000167936324000004/0001679363-24-000004-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.